NextGen Enterprise and CureMD EHR are not interchangeable platforms, and the documented differences are most visible in how each vendor structures data access and describes its own product. NextGen Healthcare publishes separate Patient Access and Enterprise API categories for NextGen Enterprise, with version-specific installation requirements and a proprietary JSON standard alongside FHIR routes [1][2]. CureMD publishes a FHIR API documentation set aimed at ONC certification and markets a single cloud platform combining EHR, practice management, and billing [9][10]. A buyer evaluating this exact pair should separate vendor marketing from documented technical behavior, because the two companies emphasize different integration models, upgrade mechanics, and clinical workflow claims. This comparison organizes those differences around decision points that a practice or health system can actually verify before procurement.
API architecture and developer access
NextGen Enterprise splits its API surface into two audiences. Patient Access APIs are available in FHIR DSTU2 and R4 standards and are intended for apps that let patients retrieve their own health data from a NextGen Enterprise practice [1]. Enterprise APIs are described as a collection of JSON-based RESTful APIs with more than 800 routes, enabling read and write transactions across EHR, practice management, and related data using a proprietary NextGen JSON data standard [1][2]. NextGen states that FHIR APIs may also be used for client-facing applications, but the Enterprise API documentation is provided only after a developer submits onboarding details [1].
CureMD describes a different registration path. Its FHIR documentation states that third-party application developers must email CureMD with application details, including app name, homepage URL, privacy policy, terms of service, OAuth redirect URLs, SMART scopes, and application type [9]. The documentation covers confidential client and public EHR launch flows, with authorization code exchange and optional JWKS or client secret authentication [9]. Unlike NextGen's split between patient and enterprise APIs, CureMD's published material frames FHIR as the primary mechanism for building integrated solutions that meet ONC's standardized API criterion [9]. The practical consequence is that a buyer's integration team will encounter different onboarding, authentication, and documentation workflows depending on the vendor.
Interoperability and data exchange scope
NextGen documents a broader set of interface categories beyond FHIR. Its interoperability page lists document interfaces using NextGen Rosetta, a proprietary HL7 interface solution, with HL7 v2.5 as the preferred standard for third-party systems [4]. It also describes immunization registry interfaces formatted to HL7 v2.3 or v2.5, laboratory interfaces based on HL7 standards, medical device interfaces for products such as Hillrom and GE CardioSoft, and PACS/RIS interfaces for systems like ScImage and FUJI [4]. Mirth Connect Integration Engine is listed separately as a tool that can receive data from multiple sources and transform or route it to external systems [4].
CureMD's public material emphasizes a unified platform rather than a catalog of named interface types. Its EMR page states that CureMD functions as a full EHR, with records following the patient across the care continuum through HL7, FHIR, and HIE connections [11]. The company also lists e-prescribing with EPCS and bi-directional lab interfaces as features [11]. However, CureMD does not publish the same level of interface-by-interface detail in the retrieved sources as NextGen does for Rosetta, immunization registries, or device categories. A buyer should request a current interface inventory from CureMD rather than assume parity with NextGen's documented list.
A suggested integration evaluation for a multi-site practice
A practice running NextGen Enterprise v5.9.0 or higher could test whether its IT team can complete the API Suite Manager installation checklist and open the two required Success Community cases before evaluating any third-party app [2]. In parallel, the same team could email CureMD with the full application registration list from its FHIR documentation, including SMART scopes and OAuth redirect URLs, to compare onboarding friction [9]. This exercise would reveal differences in documentation access, support case requirements, and authentication setup without requiring a production deployment. It is a suggested workflow, not a tested benchmark, and it does not establish which platform is faster or more reliable.
Upgrade pathways and version-specific requirements
NextGen Enterprise has a documented version dependency for its API. The Enterprise API is available for NextGen Enterprise v5.9.0 or higher, and clients are instructed to open two Success Community cases to request API Suite Manager installation, with no additional fee for the software [2]. NextGen also recommends a dedicated server to operate the Enterprise API and requires completion of a pre-installation client readiness checklist [2]. The company's Path to NextGen Enterprise 8 page describes NGE 8 as a general release with a refreshed framework, including a patient information bar, encounter history configuration, and category view for documents [3]. NextGen Enterprise 8.4 is described as a web-native platform with a continuous deployment framework [3].
CureMD does not publish an equivalent versioned upgrade pathway in the retrieved sources. Its marketing describes a flat monthly subscription with implementation and training included, and positions the platform as cloud-based [11]. The company states that switching practices receive a dedicated team with ongoing support included [11]. Without a public version history or upgrade utility guide comparable to NextGen's, a buyer cannot verify from the public documents how CureMD handles major releases, customizations, or regression testing. This is a material unknown for organizations that need to plan multi-year upgrade cycles.
Clinical workflow and AI positioning
NextGen's clinical workflow documentation centers on the Data Share module and NGE 8 enhancements. The Data Share module imports and exports CCD and C-CDA files, and requires licensing the NextGen Clinical Interface Bundle, Rosetta Interface Messenger, and HIE Gateway [8]. NextGen also documents content exclusion lists, confidential lab results filtering, and sensitive encounter flagging to limit what is exported [8]. The NGE 8 page mentions embedded Clinical AI desktop tools and specialty-specific templates, but does not provide detailed clinical efficacy claims in the retrieved anchors [3].
CureMD's public material makes stronger and more specific AI claims, which should be attributed to the vendor. CureMD states that its ambient AI medical scribe listens to the visit and produces a structured draft with suggested codes, and that the AI flags missing documentation and proposes ICD-10 and CPT codes [11][12]. The company claims a 75% reduction in chart time and a 12% increase in clean claim rate after AI coding rollout, but these figures appear in marketing pages without a published methodology or denominator [12]. CureMD also claims support for more than 30 specialties and built-in voice for English, Spanish, and 12 more languages [11][12]. Buyers should treat these as vendor assertions, not independently verified outcomes.
Practice management, billing, and revenue tools
CureMD's platform description bundles EHR, practice management, and medical billing into one system. Its practice management page lists personalized dashboards, task management, enterprise scheduling, real-time eligibility verification, claim scrubbing, denial management, and payer management [10]. The medical billing section claims a 99% customer retention rate, 98% clean claim rate, 5% to 10% increase in cash collections, and 15% to 20% decrease in cost to collect [10]. These are vendor-reported figures without source documentation in the retrieved material.
NextGen's retrieved sources focus less on billing outcomes and more on the technical infrastructure that supports revenue and clinical workflows. The Enterprise API is described as enabling read and write transactions across EHR, PM, and related data [1]. NextGen's interoperability page mentions exporting demographics, scheduling, or order messages and importing results messages for PACS/RIS systems [4]. The company does not publish comparable clean claim or collection metrics in the supplied anchors. A buyer comparing revenue cycle capabilities will need to request current billing documentation from both vendors, because the public sources are asymmetric.
Sources & references
- Public API Documentation for NextGen Healthcare ... · www.nextgen.com
- NextGen Enterprise API · successcommunity.nextgen.com
- Path to NextGen Enterprise 8 · successcommunity.nextgen.com
- Robust interfaces expand access to insights and data · www.nextgen.com
- patientapi · www.nextgen.com
- Enterprise USCDI Documentation | NextGen Healthcare · www.nextgen.com
- APIs and FHIR | NextGen Healthcare · www.nextgen.com
- Prerequisites for the Data Share Module · docs.nextgen.com
- FHIR API Documentation · www.curemd.com
- CureMD's All in One EHR, PM and Billing Solution · www.curemd.com
- EMR Software Rated #1 by KLAS - Trusted by 30+ Specialties · www.curemd.com
- The AI EHR that Gives Physicians their Time Back · www.curemd.com